Glucose transport into non neuronal brain cells uses differently glycosylated forms of the glucose trans port protein, GLUTl. Microvascular GLUTl is readily seen on immunocytochemistry, although its parenchymal localization has been difficult. Following ischemia, GLUTl mRNA increases, but whether GLUT) protein also changes is uncertain. Therefore, we examined the immunocytochemical distribution of GLUTl in normal rat brain and after transient global forebrain ischemia. A novel immunocytochemical finding was peptide inhibitable GLUTl immunoreactive staining in paren chyma as well as in cerebral microvessels. In nonisch emic rats, parenchymal GLUTl staining co-localizes with glial fibrillary acidic protein (GF AP) in perivascular foot processes of astrocytes. By 24 h after ischemia, both mi crovascular and nonmicrovascular GLUTl immunoreac tivity increased widely, persisting at 4 days postischemia.
Summary: Glucose transport into non neuronal brain cells uses differently glycosylated forms of the glucose trans port protein, GLUTl. Microvascular GLUTl is readily seen on immunocytochemistry, although its parenchymal localization has been difficult. Following ischemia, GLUTl mRNA increases, but whether GLUT) protein also changes is uncertain. Therefore, we examined the immunocytochemical distribution of GLUTl in normal rat brain and after transient global forebrain ischemia. A novel immunocytochemical finding was peptide inhibitable GLUTl immunoreactive staining in paren chyma as well as in cerebral microvessels. In nonisch emic rats, parenchymal GLUTl staining co-localizes with glial fibrillary acidic protein (GF AP) in perivascular foot processes of astrocytes. By 24 h after ischemia, both mi crovascular and nonmicrovascular GLUTl immunoreac tivity increased widely, persisting at 4 days postischemia.
The brain depends upon a continuous delivery of glucose from the bloodstream to fuel the energy re quirements associated with synaptic activity, bio synthetic functions, and other fuel needs. Because the brain has only modest glycogen stores and can not synthesize glucose, it must import this fuel. Glucose transport into brain, as into other tis sues, is accomplished by members of a family of proteins named GLUTI-7, in order of their discov-Vascularity within sections of brain similarly increased after ischemia. Increased parenchymal GLUTl expres sion was paralleled by staining for G F AP, suggesting that nonvascular GLUTl overexpression may occur in reac tive astrocytes. A final observation was a rapid expres sion of inducible heat shock protein (HSP)70 in hippo campus and cortex by 24 h after ischemia. We conclude that GLUTl is normally immunocytochemically detect able in cerebral microvessels and parenchyma and that parenchymal expression occurs in some astroglia. After global cerebral ischemia, GLUTl overexpression occurs rapidly and widely in microvessels and parenchyma; its overexpression may be related to an immediate early gene form of response to cellular stress. Key Words: Glu cose transport-Stroke-Glucose transport proteins Endothelial cells-Astrocytes-Brain metabolism. ery (Gould and Holman, 1993) . GLUTI is the pri mary brain endothelial glucose transport protein (Boado and Pardridge, 1990) . This protein has also been found in cultured brain cells lin which its pres ence might represent an artifact of culture condi tions (Hiraki et aI., 1988 ) that induce GLUTl ex pression]. GLUTI mRNA has been reported to be localized by in situ hybridization in some nonvas cular parenchymal brain cells, including astrocytes (Bondy et aI., 1992) . Although this protein is readily visualized in the cerebral microvasculature and the choroid plexus, where it is highly concentrated, im munocytochemical studies have failed to disclose its presence in parenchymal cells of the brain (Harik et aI., 1990; Farrell and Pardridge, 1991) .
During cerebral ischemia, the brain's fu el supply becomes interrupted. In experimental stroke, glu cose availability to the brain may modify the extent of brain damage from ischemia (Lundgren et al., 1990b) . It is arguable that altered glucose transport protein concentrations may be the biological equiv alent of altered glycemia (Simpson et aI., 1994) . In this regard, a disorder with brain GLUTl defi ciency, which leads to seizures and developmental delay, has been described (De Vivo et aI., 199 1) . Only a few studies, however, have examined glu cose transport (Betz et aI., 1974; Betz et aI., 1983) or glucose transporters (Gerhart et aI., 199 1) after brain ischemia. Lee and Bondy (1993) reported a marked increase in GLUT 1 mRNA and a modest increase in GLUT3 mRNA after focal cerebral ischemia. Similar findings were reported in an ani mal (gerbil) model for global ischemia (Gerhart et al., 1994) . Despite these observations on GLUT mRNA, no evidence of altered GLUTl expression has been found (in the gerbil model of global fore brain ischemia or other ischemic models) to explain the previously observed downregulation of glucose transport at the blood-brain barrier (BBB) (Gerhart et aI., 199 1) . In the present study, we determined whether parenchymal GLUT 1 may be immunocy tochemically visualized in normal conditions and whether experimental global cerebral ischemia af fects the expression of GLUT 1, the major nonneu ronal glucose transporter in brain.
METHODS AND MATERIALS

Animals
Male Sprague-Dawley rats (250-350 g), (Harlan Sprague-Dawley, Indianapolis, IN, U.S.A.) were ex posed to light between 0600 and 1800 h and were provided ad libitum access to food (Purina Rodent Laboratory Chow 5001) and water. Animals were housed in our ani mal care facility for at least 1 week prior to experiments. All experiments received prior approval by the Animal Care Committee of the Oregon Health Sciences Univer sity or the Portland Veterans Administration Animal Care committee and were in keeping with American Associa tion for Accreditation of Laboratory Animals guidelines.
Ischemia model
The model of global ischemia was the two-vessel oc clusion-hypotensive model of global forebrain ischemia that has been extensively characterized by Siesjo and co workers (Lundgren et aI., 1990b; Lundgren et aI., 1990a; Kozuka et aI., 1989; Inamura et aI., 1988 ) and that we have described elsewhere (McCall et aI., 1995) . Animals were divided into groups (including sham-operated con trols) according to the duration of time after ischemia (24 h or 4 days). All animals were fasted the night before surgery. Forebrain ischemia was produced by clamping the common carotid arteries bilaterally, after abruptly lowering the mean arterial pressure to 25 torr by rapid withdrawal of 4--10 ml of blood. Arterial pressure was kept at 25 torr for the duration of the ischemic period by addition or removal of small amounts of blood. After 15 min, the carotid arteries were unclamped and the blood reinfused. Rats received tracheal intubation for adminis tration of halothane, nitrous oxide, and oxygen anesthe sia with a tidal volume of 2-2.5 ml at a rate of 80 ± 2 J Cereb Blood Flow Metab, Vol. 16, No. 1, 1996 respirations per min. Animals were routinely monitored by electrocardiography (ECG), electroencephalography (EEG), blood pressure by indwelling arterial catheter and arterial blood gas concentrations, the latter of which were kept in the normal range of pH (7.3{}"'7.40) and Pcoz (3{}'" 40 torr) by adjustments of the mechanically controlled rodent ventilator (Harvard Apparatus, South Natick, MA, U.S.A.). Temperature was monitored through a rec tal probe and maintained at 36.5-37 SC with a heating pad. For sham-operated controls, the animals were treated identically save that the carotid arteries were not clamped, and no blood was withdrawn from the jugular catheter. After ischemia, animals were observed for an esthesia recovery, behavioral manifestations of neuro logic injury, and health. Ischemic lesions were subjected to routine histology using acid fuchsin, thionin stains, and estimations of injury using OX-42.
Perfusion and immunocytochemistry
We used a special secondary immunization procedure (Van Bueren et aI., 1993) to generate a high titer anti serum against the 14 carboxyl terminal amino acids (PEELFHDLGADSQV) of GLUTl. The native peptide was conjugated to keyhole limpet hemocyanin (KLH) by an amino terminal cysteine. This antiserum was used for immunolocalization of GLUTl in parenchyma and mi crovessels. Animals were anesthetized and perfused for immunocytochemistry, which was performed as previ ously described (Van Bueren et aI., 1993; Ju et aI., 1989; McCall et aI., 1995) . Sections were incubated and washed in phosphate-buffered saline (PBS) and incubated over night in blocking solution containing 2% normal goat se rum (NGS), Triton X-IOO (0.3%) in 0.02 M potassium phosphate-buffered saline (KPBS), followed by overnight incubation at 4°C with the primary antibodies, e.g., the polyclonal rabbit anti-GLUTl antibody, ALM1-K, 1:5,000 (Van Bueren et aI., 1993) diluted in 0.02 M KPBS with 2% NGS. This was followed by incubation with a biotinylated goat anti-rabbit IgG using the ABC kit (Vec tor Labs). The peroxidase reaction was carried out with diaminobenzidine (DAB) (0.3 mg/m!) in the presence of hydrogen peroxide (0.03%). Specificity of immunocyto chemistry was assessed regularly by peptide competition (10 ILg/ml of GLUTl immunogen; see Figs. 1D and 3D--F and preimmune serum controls. Glial fibrillary acidic pro tein (GFAP) immunoreactivity was assessed using a mouse monoclonal antibody SMI-26 (Sternberger Mono clonals Inc.). It was visualized with a biotinylated goat anti-mouse IgG (Organon Teknika, Darham, NC, U.S.A.) or a goat anti-mouse IgG conjugated to Texas red (Vector Laboratories, Inc., Burlingame, CA, U.S.A.). Inducible heat shock protein (HSP 70) was visualized with the per oxidase reaction as previously described using commer cially available antibodies (Kinouchi et aI., 1993) .
To provide estimates of increases in optical density for nonvascular GLUTI in brain sections, we measured den sitometry for GLUTl immunoreaction density in five readings per field each in sham-operated control rats (n = 2) and groups of postischemic rats at 24 h (n = 4) and 4 days (n = 2) in four hippocampal areas: molecular layer of the dentate gyrus, stratum oriens and stratum radiatum in the CAl regions of the hippocampal formation, and hilus (also known at the CA4 region) of the dentate. These density measures were summed (numbers of observa tions; n = 2 for control, n = 4 for 24 h, and n = 2 for 4 days postischemic) to give an index of overall GLUTl and 18 ), 20 f.l.g protein from rat forebrain mem-40 branes containing (lanes 2A and 28) and devoid (lanes 3A and 38) of cerebral microvessels, and 0.5 f.l.g of protein from human red blood cells (lanes 4A and 48). C: Immu nocytochemical staining of both microvessels and parenchyma by ALM1-K (1 :5,000) and a 10 f.l.g/ml peptide preadsorption comparison (D).
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A staining. These density measurements represent only nonvascular GLUTI immunoreactive staining. Using a freehand cursor tracing, all microvascular GLUTl stain ing was excluded prior to making densitometric calcula tions.
In order to assess the GLUTI overexpression in rela tion to vascularity, we counted the number of microves sel segments in sections through the anterior hippocam pus in four high powered fields of cortex (two on left, two on right) and hippocampus from each animal.
Western blot analysis
Rat forebrains were dissected and the pia mater re moved. Brains were homogenized with a Dounce homog enizer and the microvessels isolated on 1.5 and 1.0 M sucrose density gradients as previously described (Suss man et aI., 1988) . The remaining homogenate represented a microvessel-depleted filtrate. Choroid plexus was dis sected from 10 rat forebrains using coronal sections through the anterior hippocampus. Samples were lysed and separated on a 10% SDS-PAGE gel and immunoblot ted as previously described (Van Bueren et aI., 1993) . For primary antibody, ALMI-K at 1:5,000 dilution was used. Molecular weights were estimated on immunoblots using Amersham rainbow standards.
Data presentation and statistical analyses
Data are expressed as means ± SD except for measures of hippocampal GLUTl density, which are expressed as a scatter plot (Fig. 4) of summed optical densities from four hippocampal areas. Comparisons of the optical den sity of GLUTl immunoreactive staining and vascularity between groups were assessed by Spearman rank order nonparametric correlation analysis and one way analysis of variance (ANOV A) respectively. Post hoc mUltiple comparisons were performed using a Newman-Keuls test. rum, ALMI-K (l :5,000) in different membrane frac tions from normal rat brain. Lane I shows mem branes from choroid plexus (10 f,Lg protein by Lowry assay) with two bands of -45 and 48 kDa; lane 2 shows rat forebrain homogenate membranes (20 f,Lg protein) with a microvessel GLUTl band at -55 kDa and parenchymal bands at 47 and 40 kDa; lane 3 shows microvessel-depleted (Sussman et aI., 1988) rat forebrain homogenate membranes (20 f,Lg protein), displaying only the lower molecular weight parenchymal bands (Vannucci, 1994) ; and lane 4 shows human red blood cells (0.5 f,Lg; a broad band from 40-57 kDa). Antigen specificity of our antiserum is suggested by the tissue distribution (Simpson et aI., 1994; Maher et aI., 1994) and ab sence of immunoreactivity after peptide preabsorp tion with 10 f,Lg/ml immunizing peptide (Fig. IB) . Identical immunoreactivity is seen with these sam ples with other carboxyl-terminal or whole GLUTl protein-directed antisera (antiserum 379 or H-se rum, respectively, courtesy of Dr. Ian Simpson, National Institute of Diabetes and Digestive Kidney Diseases) (Simpson et aI., 1994) . Figure I C shows a 50 f,Lm section from a control rat brain. Figures IC and 2A illustrate the immuno reactive staining of ALMI-K (1:5,000), our car boxyl-terminus directed antibody against GLUTI. As shown here and by others previously (Harik et aI., 1990) , immunoreactivity is visible within the ce rebral vasculature. Both small and larger blood ves sels, which appear as tubular structures that are on a bias within these relatively thick (50 f,Lm) sections, are seen. Also visible in this section, but not previ ously demonstrated is diffuse staining of the paren-FIG. 2. Co-localization of GLUT1 and GFAP in normal rat brain. GLUT1 immunoreactivity with ALM1-K (1 :5,000) by light micros copy is shown in a section of normal adult rat brain (A) at left. In the same field, shown at the right, visualization with Texas-red under darkfield illumination demonstrates GFAP-positive astrocytes (B ) . The white arrowhead points to perivascular astrocyte staining in a microvessel; the black arrowhead points to perivascular astrocyte staining in a larger blood vessel.
RESULTS
Figure
chyma. It is noteworthy that large neuronal cell bodies, visible, e.g., within the pyramidal cell layer of the hippocampus or in its granule cell layer, ap pear devoid of staining (Fig. 3A) . GLUT3, the neu ron-specific transporter, exhibits a similar pattern but there appears to be no cross reaction between GLUTl and GLUT3 as assessed by peptide com petition and tissue distribution (McCall et ai., 1994) . Evidence for the specificity of staining of the an tiserum is illustrated by peptide competition with 10 f1g/ml of GLUTl peptide (Fig. ID) . Figure 2 shows immunoreactive co-localization of GLUTl with GFAP in a section from a nonisch- GF AP immunoreactivity is prominently visible in several cells in this section. Several perivascular GFAP reactive cells, i.e., astrocytic foot processes, have clear co-localization of GLUTl and GFAP, as noted by arrowheads. Figure 3 illustrates the GLUTl staining in sham, 24 h post-ischemic, and 4-day post ischemic rats with sections taken at the level of the anterior hip pocampus, The left panels show uncompeted GLUTl immunoreactivity (ALMI-K; 1:5,000) from sham-operated control rats (A) and animals either 1 (B) or 4 days (C) after exposure to global forebrain ischemia. The right panels show the respective pep tide competition controls (10 f1g/ml preincubation with ALMI-K for 2 h). As shown here, a diffuse increase in the expression of GLUTI occurs in both parenchymal cells and in the microvasculature of the brain at 24 h and 4 days after ischemia. There is no significant nonspecific immunoreactive staining in either sham-operated or ischemic animals.
In Fig. 4 , the summed densitometric measure ments are shown for four hippocampal areas. Data are shown as a scatter plot of the sums of the den sities in four hippocampal areas for each animal. As assessed by the Spearman rank order correlation test, the groups show a progressive rise in nonvas cular GLUTl immunoreactivity after ischemia (p < 0.05). Figure 5 shows a higher power magnification of sections of cerebral cortex from sham-operated (A), 24-h postischemic (B), and 4-day postischemic (C) rats to exemplify the altered vascularity seen after global ischemia. As is shown in this figure, the in crease in GLUTI staining seen in the microvascu- lature occurs within a context of increased vascu larity, i.e., within sections, there are more mi crovessels with longer, more contiguous segments within the plane of the section, and the brain capil laries exhibit a more tortuous appearance. 
Sham 24h 4d
Condition To document altered vascularity after ischemia, Fig. 6 shows the counts of microvessel segments per mm 2 for sham-operated, 24 h and 4-day post ischemic rats. At 24 h after ischemia, cortex mi crovessel segments increased by 50% and hippo campal microvessel segments by 80%. At 4 days after global ischemia, the increase was 29% greater than controls in the cortex and 64% greater than controls in the hippocampus.
The increased parenchymal GLUTI immunore active staining within the cortical areas exposed to ischemia is widespread but not uniform. In some animals, GLUTI immunoreactive staining-as as sessed by visual inspection-was increased from frontal cortex to portions of the cerebellum; in oth ers, staining was less widespread, although it was consistently visible outside of the hippocampal CAl region and adjacent cortex known to be vulnerable in this form of ischemic insult (McCall et al., 1995) . GLUTI parenchymal staining corresponds closely with increased GF AP staining (Fig. 7) GLUTI immunoreactivity does not correlate well with other markers of ischemic damage, e.g., thio nin staining for neuronal dropout or microglial ac tivation markers such as OX-42 (McCall et aI., 1995) . A final observation potentially relevant to GLUTl expression is shown in Fig. 8 . We found that inducible HSP70 immunoreactive staining was increased rapidly (by 24 h postischemia) within the areas in which GLUTI immunoreactive staining in creased. The correspondence of HSP70 and GLUTl immunoreactive staining was largely lost, however, by 4 days after ischemia.
DISCUSSION
These data show that a high titer antibody for GLUTI can permit specific immunocytochemical visualization of the less concentrated parenchymal form of that protein in nonischemic brain tissue. Evidence for specificity of this staining includes Western blot analysis, which showed appropriately sized, peptide-inhibitable bands that are distributed in a tissue-specific manner. Use of other GLUTI antisera in Western blot analysis of these same tis sues gave similar patterns. Immunocytochemical staining for GLUTl was also peptide-inhibitable, and background staining with lO j.1g/ml of immuniz ing peptide preincubated with immune antisera was very low (Figs. 1 and 3) .
Another major finding shown here is that global forebrain ischemia produced a considerable in crease in expression of both parenchymal and mi crovascular GLUTI protein. Lee and Bondy re ported that focal brain ischemia markedly induces GLUTl gene expression (as well as modest in creases in GLUT3 mRNA), using in situ hybridiza tion (Lee and Bondy, 1993) . Similarly, Gerhart et al. (1994) recently reported increases in GLUTl and GLUT3 mRNAs after global ischemia in a gerbil model. There has been little evidence, however, that GLUTl protein also responds to ischemia in the adult brain (Gerhart et al., 1991) . Preliminary data have suggested that increased GLUTl protein expression may occur with neonatal hypoxial ischemia (S. Vannucci, unpublished observations). The explanation for the different findings after isch emia is not known. The combination of increased GLUTl mRNA from these two reports combined with our observation of increased GLUTI protein expression suggests a possible transcriptional regu lation.
While the mechanism for increased GLUT 1 ex pression is unknown, such increased expression could represent an immediate early gene form of transcriptional cellular response to stress and hyp oxia (Collaco-Moraes et al., 1994) . GLUTl expres sion is induced in culture by cellular metabolic stress (Wertheimer et al., 1991) . Induction of GLUTI also occurs in cell culture in response to serum (Hiraki et al., 1988) and proto-oncogenes (Flier et al., 1987) , and the GLUTl gene has been found to have a serum response element in the 5/ untranslated region (Murakami et al., 1992) . The early parallel induction of HSP70 immunoreactive staining that we have observed could be relevant, since its induction accompanies the cellular activa tion that characterizes the immediate early gene re sponse (Nowak TS, 1990) .
Induction of GLUTl and GLUT3 mRNAs occurs after brain ischemia (Lee and Bondy, 1993; Gerhart et al., 1994) . We have not, however, found any in crease in immunoreactive GLUT3 protein-the neuronal glucose transporter-in our model of glob al ischemia (McCall et al., 1995) , pointing to a spec ificity of the transporter response.
Precise cellular localization and subcellular sites of GLUTI protein overexpression are not yet char acterized. Co-localization of GLUTl protein and GF AP in nonischemic animals confirm and extend prior observations about GLUTl mRNA localiza tion (Bondy et al., 1992) . A comprehensive analysis will be required to determine whether ectopic (e.g., neuronal) expression of GLUTI protein occurs af ter ischemia as is suggested by in situ hybridization data (Lee and Bondy, 1993) . The marked increase in GF AP staining after global ischemia observed in the current study and the correspondence of in creased GFAP staining with GLUTl protein over expression points to reactive astrocytes as one im portant source of the overexpression.
The idea has been advanced that altered GLUT expression in the brain may be functionally equiv alent to altered glycemia with loss of transporter equal to glucoprivation (Maher et al., 1994; Simp son et al., 1994) . A corollary implication is that the concentrations of glucose transporters within the brain may affect cellular metabolism of brain re gions. If these ideas are correct, then our current observations support the suggestion that GLUTl overexpression, by equaling hyperglycemia, influ ences brain metabolism after ischemia. Certainly, the combination of increased expression of GLUTI and the associated increased vascularity, found in this study, suggests a potential compensatory re sponse to fuel deprivation. Increased vascularity and glucose transporter induction have recently been reported in response to long-term (weeks) hy pobaric hypoxia (Harik et al., 1994) . We are not aware, however, of occurrence of these responses in other situations within such a short (24 h) period. The consequences of these responses for recovery from ischemia need to be determined.
